Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: A phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the gynecologic oncology group)

Seminars in Oncology

Volumn 23, Issue SUPPL. 12, 1996, Pages 40-47

  McGuire, W P ^a   Hoskins, W J ^a   Brady, M F ^a   Kucera, P R ^a   Partridge, E E ^a   Look, K Y ^a   Clarke Pearson, D L ^a   Davidson, M ^a  

^a GOG Admmistrative Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; PACLITAXEL;

ALOPECIA; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; FEMALE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; NEUROPATHY; NEUTROPENIA; OVARY CANCER; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PACLITAXEL; PROSPECTIVE STUDIES; SALVAGE THERAPY;

EID: 0029802958     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)